Sign Up to like & get
recommendations!
0
Published in 2018 at "Reviews in Endocrine and Metabolic Disorders"
DOI: 10.1007/s11154-018-9469-9
Abstract: The incidence of neuroendocrine tumors (NET) increases with age. Lately, the diagnosis of NET was mainly caused by early detection of small NET (
read more here.
Keywords:
surgery;
patients neuroendocrine;
curative palliative;
neuroendocrine tumors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Gastroenterology"
DOI: 10.1053/j.gastro.2017.11.008
Abstract: BACKGROUND & AIMS Survival times vary among patients with neuroendocrine tumors (NETs) - even among those with the same site, stage, and grade of primary tumor. This makes it difficult to select treatment for patients…
read more here.
Keywords:
tumor volume;
patients neuroendocrine;
68ga dotatate;
dotatate ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000016508
Abstract: Abstract Rationale: There is an association between the presence of neuroendocrine neoplasms and incremented risk to develop second primary malignancies. This risk is estimated to be 17%. The most common secondary neoplasms were found in…
read more here.
Keywords:
second primary;
primary malignancies;
occurrence second;
malignancies patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13269
Abstract: Pancreatic metastases (PMs) from neuroendocrine neoplasms (NENs) are rare but the increased sensitivity of new diagnostic tools such as 68Ga‐DOTATATE PET/CT has resulted in their increased recognition at initial diagnosis or follow‐up. A retrospective analysis…
read more here.
Keywords:
metastases patients;
neoplasms multi;
pancreatic metastases;
pms ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Oncology"
DOI: 10.1159/000502384
Abstract: Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies with various clinical presentations and growth rates. NET incidence has been estimated to 2.5–5 per 100,000 people per year, and NET prevalence is 35 per…
read more here.
Keywords:
synchronous cancers;
patients neuroendocrine;
metachronous synchronous;
neuroendocrine tumors ... See more keywords